Aoyuan Healthy Life Group Co. Ltd. (3662) AI Stock Analysis

• Market Cap: HK$399.44M
• Dividend Yield: 5.22%
• Average Volume (3M): 449.51K
• Price to Earnings (P/E): 3.8
• Beta (1Y): 0.89
• Revenue Growth: -14.98%
• EPS Growth: -39.71%
• Country: HK
• Employees: 1,895
• Sector: Real Estate
• Sector Strength: 53
• Industry: Real Estate - Services
• EPS (TTM): 0.02
• Shares Outstanding: 726,250,000
• 10 Day Avg. Volume: 381,000
• 30 Day Avg. Volume: 449,506
• PEG Ratio: -0.12
• Price to Book (P/B): 0.29
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 11.04
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 67 Neutral
• Price Target: ―

Aoyuan Healthy Life Group Co. Ltd. presents a complex investment picture. Its strong balance sheet with low leverage and solid equity position supports financial resilience. However, declining revenue and profitability, coupled with negative cash flow from operations, signal operational challenges. The stock's technical indicators suggest mixed momentum, with potential support over the longer term. Valuation metrics appear favorable, indicating undervaluation. The absence of recent earnings call insights or corporate events leaves the financial and technical analyses as primary factors in evaluating this stock.

Aoyuan Healthy Life Group Co. Ltd. Business Overview & Revenue Model

Company Description

Aoyuan Healthy Life Group Co. Ltd. (3662) is a prominent Chinese company specializing in property management and commercial operational services. The company operates primarily in two sectors: property management services, which include a range of services such as security, cleaning, gardening, and repair and maintenance, and commercial operational services, which involve the management of shopping malls, office buildings, and other commercial properties. Aoyuan Healthy Life Group aims to enhance living environments and provide comprehensive management solutions to residential and commercial properties across China.

How the Company Makes Money

Aoyuan Healthy Life Group Co. Ltd. generates revenue through its property management and commercial operational services. The property management segment earns income by providing essential services to residential communities, such as security, cleaning, and maintenance. Fees are typically based on the size and type of the property being managed, as well as the specific services provided. The commercial operational services segment contributes to revenue by managing and operating commercial properties, including shopping centers and office buildings, where the company earns fees related to the leasing and management of these spaces. Additionally, Aoyuan Healthy Life Group may engage in strategic partnerships to enhance its service offerings and expand its market presence, although specific partnerships are not detailed.

Aoyuan Healthy Life Group Co. Ltd. Financial Statement Overview

Summary

Aoyuan Healthy Life Group Co. Ltd. shows a mixed financial performance. The income statement reveals declining revenue and profitability margins, indicating challenges in maintaining growth and operational efficiency. The balance sheet, however, is robust with low leverage and strong equity, suggesting resilience. Cash flow analysis reveals potential concerns with negative operating cash flow, which may hinder future growth and investment capabilities. Overall, while the company maintains a strong financial position, declining earnings and cash flow trends pose risks that need to be addressed.

Income Statement

The company has experienced declining revenue over the past few years, with a significant drop from 2020 to 2021, and a continued decline through 2024. Gross Profit Margin (28.41% in 2024) has been relatively stable, but Net Profit Margin has deteriorated, dropping from 17.83% in 2020 to 7.10% in 2024. The EBIT and EBITDA margins have also shown a downward trend, reflecting decreasing operational efficiency.

Balance Sheet

The company maintains a strong equity position with an Equity Ratio of 51.00% in 2024, indicating a solid foundation and reduced financial risk. The Debt-to-Equity Ratio is low at 0.07, showing conservative leverage management. Additionally, Return on Equity has decreased slightly over the years, reflecting reduced profitability. However, the company’s high cash reserves relative to its debt provide a buffer against financial instability.

Cash Flow

The cash flow situation is mixed. Operating Cash Flow has turned negative in 2024, indicating potential challenges in generating cash from core operations. The Free Cash Flow has also declined, with significant negative trends in prior years. The ratio of Operating Cash Flow to Net Income has been inconsistent, showing volatility in cash generation relative to earnings.

Breakdown	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	1.36B	1.56B	1.63B	1.94B	1.41B
Gross Profit	385.04M	399.62M	397.21M	469.57M	481.38M
EBITDA	160.95M	198.54M	245.27M	-108.96M	368.71M
Net Income	96.22M	157.14M	160.41M	-197.29M	251.11M
Balance Sheet
Total Assets	2.36B	2.28B	2.22B	2.29B	2.55B
Cash, Cash Equivalents and Short-Term Investments	1.05B	984.50M	826.18M	1.21B	1.51B
Total Debt	81.69M	114.94M	158.29M	412.59M	518.52M
Total Liabilities	1.11B	1.13B	1.23B	1.50B	1.49B
Stockholders Equity	1.20B	1.10B	931.48M	747.32M	1.04B
Cash Flow
Free Cash Flow	107.61M	93.52M	-108.95M	-98.54M	505.54M
Operating Cash Flow	140.33M	106.01M	-105.68M	-86.34M	531.10M
Investing Cash Flow	-30.53M	67.93M	-50.65M	31.09M	-225.22M
Financing Cash Flow	-51.28M	-48.34M	-272.10M	-245.32M	376.79M

Aoyuan Healthy Life Group Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 0.55
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:3662, the sentiment is Positive. The current price of 0.55 is above the 20-day moving average (MA) of 0.53, above the 50-day MA of 0.52, and above the 200-day MA of 0.50, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 50.23 is Neutral, neither overbought nor oversold. The STOCH value of 75.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:3662.

Aoyuan Healthy Life Group Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
2165	77 Outperform	HK$382.82M	4.30	14.22%	―	5.20%	-21.61%
2376	72 Outperform	HK$266.68M	5.45	8.33%	5.90%	-3.67%	―
3662	67 Neutral	HK$399.44M	3.83	8.37%	5.22%	-14.98%	-39.71%
2107	57 Neutral	HK$367.16M	5.21	-1.62%	10.82%	7.48%	-118.08%
Sector *	53 Neutral	$1.20B	3.25	-0.13%	7.08%	-1.64%	-127.49%
9608	49 Neutral	HK$357.12M	120.00	0.77%	―	-7.55%	-75.00%

Aoyuan Healthy Life Group Co. Ltd. Corporate Events

Starjoy Wellness and Travel Announces Board Composition

Starjoy Wellness and Travel Company Limited has announced the composition of its board of directors, which includes executive, non-executive, and independent non-executive directors. The board is chaired by Mr. Wang Jiren, who also serves as the president, with Ms. Liang Jinrong as the chief financial officer and vice president. The announcement provides details on the roles and functions of each board member, as well as their membership in various board committees, which include audit, remuneration, and nomination committees.

Starjoy Wellness Updates Nomination Committee Terms

Starjoy Wellness and Travel Company Limited has amended and restated the terms of reference for its Nomination Committee. The committee, consisting of at least three members with a majority being independent non-executive directors, is responsible for overseeing nominations to the board. This move aims to ensure diverse and independent oversight in board appointments, potentially enhancing governance and strategic decision-making within the company.

Starjoy Wellness and Travel Updates Nomination Committee for Enhanced Governance

Starjoy Wellness and Travel Company Limited has announced a change in the composition of its Nomination Committee. Ms. Liang Jinrong, an executive director, has been appointed as a member of the Nomination Committee, effective from May 29, 2025. This change aligns with the amended Corporate Governance Code, which will be effective from July 1, 2025, and aims to enhance the company’s corporate governance by increasing diversity and effectiveness within the board.

Starjoy Wellness and Travel Company Limited Secures Shareholder Approval for Key Resolutions at AGM

Starjoy Wellness and Travel Company Limited, along with its subsidiaries, held its Annual General Meeting on May 27, 2025, where all proposed resolutions were approved by shareholders. The resolutions included the adoption of financial statements, declaration of a final dividend, re-election of directors, re-appointment of auditors, and granting of mandates to the board for share repurchase and issuance. The unanimous approval of these resolutions reflects strong shareholder support and positions the company for continued operational and strategic initiatives.

Starjoy Wellness and Travel Announces AGM and Key Resolutions

Starjoy Wellness and Travel Company Limited, a subsidiary of Aoyuan Healthy Life Group Co. Ltd., has announced its upcoming annual general meeting (AGM) scheduled for May 27, 2025. During the AGM, the company will address several key issues, including the adoption of financial statements, declaration of a final dividend, re-election of directors, and re-appointment of auditors. Additionally, the company seeks shareholder approval for mandates to repurchase shares and issue new shares, which could impact its market operations and shareholder value.